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Abstract
Background: There are several existing systematic reviews of prevalence of dementia for
mainland China, Hong Kong and Taiwan, but several studies have been newly reported.
The aim of this study is to update prevalence data in this region and test for variation
across geographical areas and time periods using the new dataset.
Methods: Twenty prevalence studies identified from World Alzheimer Report 2015
(January 2011–March 2015) and an updated search (March 2015–February 2017) were
added to the original dataset (N ¼ 76). Meta-regression was used to investigate geo-
graphical variation and time trends, taking methodological factors and characteristics of
study population into account, and to estimate prevalence and number of people with
dementia by geographical area.
Results: Compared with northern China, the prevalence of dementia was lower in the
central China [-1.0; 95% confidence interval (CI):2.2, 0.3], south China (1.7; 95% CI:
3.1, 0.3), Hong Kong and Taiwan (3.0; 95% CI: 5.0, 1.0) but appeared to be higher
in western China (2.8; 95% CI: 0.1, 5.5) after adjusting for methodological variation. The
increasing trend from pre-1990 to post-2010 periods was considerably attenuated when
taking into account methodological factors and geographical areas. The updated esti-
mated number of people with dementia in all these areas is 9.5 million (5.3%; 95% CI: 4.3,
6.3) in the population aged 60 or above.
Conclusions: Geographical variation in dementia prevalence is confirmed in this update,
whereas evidence on increasing trends is still insufficient. Differing societal development
across areas provides an opportunity to investigate risk factors at the population level
VC The Author(s) 2018. Published by Oxford University Press on behalf of the International Epidemiological Association. 1
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operating across diverse life course experiences. Such research could advance global
primary prevention of dementia.
Key words: Dementia, prevalence, China, Hong Kong, Taiwan, meta-analysis
Introduction
Dementia, a syndrome of cognitive decline and a major
cause of disability in older age, has become a global public
health priority in the context of population ageing.1,2 The
worldwide epidemiology of dementia has been an import-
ant topic, as it provides fundamental information for de-
mentia research, charity lobbying and policy planning.1
Since the turn of the millennium, many prevalence studies
of dementia have been conducted in low- and middle-in-
come countries, with China being among these.3 Estimated
prevalence and number of people with dementia in China
have been reported in some multicentre prevalence stud-
ies4–6 and systematic reviews.7–12
Although the earlier literature suggests a lower preva-
lence in China compared with Western Europe and other
high-income countries,1,7,13 systematic reviews including
more recent studies have reported higher estimates and
indicated a dramatic increase in prevalence over time.8,9,12
However, these analyses did not fully take into account
methodological features of individual studies. Changes in
diagnostic criteria and research methods can influence de-
mentia case identification considerably, and therefore these
results might not reflect the true prevalence trend in the
Chinese older population. In addition, the existing reviews
have generally estimated the number of people with de-
mentia based on a single set of pooled prevalence esti-
mates, and have not considered variation within this
region.9,12 China, Hong Kong and Taiwan have had very
different historical, economic and societal contexts as well
as various trajectories of life expectancy and health status.
Variations within China, one of the largest countries in the
world, have seldom been fully explored.
Our earlier meta-analytical review has covered the
prevalence studies of dementia from mainland China,
Hong Kong and Taiwan published before April 2012, and
identified important methodological factors related to the
heterogeneity of prevalence estimates. The findings reveal
north-south geographical variation and a fluctuating time
trend in dementia prevalence when taking into account
methodological factors.10,11 With rising global attention to
population ageing and dementia, several new prevalence
studies have been conducted in China, Hong Kong and
Taiwan and published in the past 5 years. This provides an
opportunity to update prevalence data in these areas and
review the findings from previous analyses. Building on
our earlier reviews,10,11 the analysis here updates the
prevalence estimates for mainland China, Hong Kong and
Taiwan and investigates whether adding these new data
changes the results from the previous analyses.
Methods
Literature search and data extraction
This study included three systematic reviews: our earlier re-
view (up to April 2012),11 World Alzheimer Report 2015
(January 2011–March 2015)12 and an updated search
(March 2015–February 2017). The literature searches
were conducted to identify prevalence studies of dementia
in English (PubMed, Web of Knowledge) and Chinese
Key Messages
• This review incorporates 96 prevalence studies of dementia in mainland China, Hong Kong and Taiwan from previous
systematic reviews, and an updated search including both English and Chinese literature published until February
2017.
• The decreasing prevalence of dementia from northern, central and southern China to Hong Kong and Taiwan was
confirmed in this update. A high prevalence in western China was identified in this new analysis.
• The increasing time trend was substantially attenuated after adjusting for methodological variation and geographical
areas, and regional trends showed considerable fluctuations.
• The updated estimated number of people with dementia in all these areas is 9.5 million, which is higher than the pre-
vious estimate (8.4 million).
2 International Journal of Epidemiology, 2018, Vol. 0, No. 0
Downloaded from https://academic.oup.com/ije/advance-article-abstract/doi/10.1093/ije/dyy007/4850989
by University of Cambridge user
on 03 April 2018
databases (Chinese National Knowledge Infrastructure
(CNKI), WanFang and Airiti Library). The same search
strategy and inclusion/exclusion criteria reported in the
earlier review10 were used to select included studies for
World Alzheimer Report 201512 and the update search.
The PRISMA guidelines14 were followed and more de-
tailed information on the search strategy is reported in
Supplementary material S1, available as Supplementary
data at IJE online. Inclusion criteria were: (i) cases were
collected by field survey, not based on hospital data;
(ii) the study involved population sampling rather than re-
cruiting volunteer participants; (iii) the study reported
prevalence in people aged 50 and over; and (iv) dementia
case identification was not solely decided by a screening
test and specific instruments and criteria were reported.
Studies were excluded if they were: (i) duplicate; (ii) irrele-
vant or with other focuses (such as mild cognitive impair-
ment); (iii) the results of follow-up waves; and (iv) focused
on Chinese populations outside mainland China, Hong
Kong and Taiwan. A full list of included and excluded
studies is provided in Supplementary material S1.
Information on study design (sampling method, one/
two-stage investigation), methodological factors (screening
tools, diagnostic criteria and instruments), characteristics
of population (sample size and response rate, the whole
study age range and locations) and results (prevalence of
all types of dementia and stratified prevalence by age) was
extracted from each study. The results of a recent study in
Hong Kong15,16 were obtained from a government docu-
ment, as the data of dementia prevalence have not been
fully published in peer reviewed journals. Data extracted
from the new prevalence studies were added to the earlier
76 studies, and study quality was assessed based on sample
size, study design, response rate and diagnostic assess-
ment.12 More detailed information on characteristics and
quality assessment of all included studies is provided in
Supplementary material S2, available as Supplementary
data at IJE online.
Geographical areas
The provinces and cities in mainland China were
categorized into three large geographical areas: north
(Beijing, Hebei, Heilongjiang, Henan, Liaoning, Shaanxi,
Shandong, Shanxi and Tianjin), central (Anhui,
Chongqing, Hubei, Hunan, Jiangsu, Jiangxi, Shanghai,
Sichuan and Zhejiang) and south (Fujian, Guangdong,
Guangxi, Guizhou and Hainan).10 Sine the update search
found additional studies from north-western areas, studies
from Xinjiang and Gansu were separated and categorized
into one group (west). Studies from Taiwan and Hong
Kong were combined in one group. One multicentre study6
including five study centres (Changchun, Beijing,
Zhengzhou, Guiyang and Guangzhou) was categorized in
one group with other multicentre studies.
Time periods
Time period was categorized into six groups on the
basis of the initial year of investigation (not publication
year): before 1990, 1990–94, 1995–99, 2000–04,
2005–09 and 2010–15. Compared with the previous re-
view, the last period group was further divided into two
groups as the new prevalence studies were generally con-
ducted after 2010. For studies that did not report the
year of investigation in the paper, the publication year
minus 3 years was used as an approximation for the
survey date.
Data analysis
To compare results from the earlier review and this up-
date, the same analytical methods reported in the previ-
ous analysis10 were used to analyse the data. Prevalence
estimates extracted from individual studies were
standardized to the Census Population of China 2010.17
A random-effect meta-analysis was used to calculate
pooled estimates of overall prevalence among all included
studies (age 50 or above) as well as stratified prevalence
by 5-year age groups, gender, methodological factors,
geographical areas and time periods. I-square was used to
indicate consistency of results across studies.18 An age-
standardized meta-regression was conducted to explore
whether the variation in prevalence estimates can be
related to methodological factors or characteristics of
study populations, and to investigate difference across
geographical areas and time periods taking into account
study design and methodological factors. A univariable
model was conducted to identify important methodo-
logical factors related to variation in prevalence esti-
mates, and the models for geographical areas and time
periods were carried out separately. A multivariable
model was fitted including geographical areas, time peri-
ods and all important methodological factors identified
from the univariable analysis. To investigate trends in
geographically defined areas, subgroup analysis was con-
ducted of the 24 studies in Beijing (north) and Shanghai
(central), the two areas with the earliest studies in the
pre-1990 period group, as well as northern and central
areas.
The results of meta-regression modelling were used to
estimate the number of people with dementia, taking into
account methodological factors. Predicted prevalence by
the five areas was estimated from the full model including
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methodological factors, geographical areas and time peri-
ods. These estimates were based on Diagnostic and
Statistical Manual of Mental Disorders (DSM)-IV/-IV-R,
the relatively new diagnostic criteria for dementia among
the included studies, and were calculated for the popula-
tion aged 60 or above in China and aged 65 or above in
Hong Kong and Taiwan, due to difference in life expect-
ancy and age range of the included studies. Age-stratified
prevalence was calculated based on regional estimates
from meta-regression modelling and the assumption of
doubling prevalence with every 5 years, which has been
confirmed by worldwide evidence on dementia epidemi-
ology.1 The stratified prevalence by 5-year age groups
applied to population structures in China, Hong Kong and
Taiwan. More detailed information on calculation meth-
ods is provided in Supplementary material S3, available as
Supplementary data at IJE online.
Results
The literature search identified 22 studies published be-
tween April 2012 and February 2017 (Figure 1). Fifteen
were in Chinese and seven in English. Two English papers
contained the same information as the Chinese publica-
tions.19,20 Information from 20 studies was added to the
earlier prevalence database. In total, 96 prevalence studies
of dementia (76 from the previous review) were included
in this analysis. Among the 20 new studies, 18 were from
China and two recent studies were found in Taiwan30 and
Hong Kong.15,16
Among the 96 studies reporting the prevalence of de-
mentia in people aged 50 or above, the pooled estimate
was 4.4% [95% confidence interval (CI): 4.4, 4.8] with a
range from 0.6% to 22.0% (Figure 2). The heterogeneity
was extremely high (I2 ¼ 98.6%). The overall estimates
were 3.7% (95% CI: 3.2, 4.1) in men and 5.6% (95% CI:
5.0, 6.2) in women. Age-stratified prevalence of dementia
was approximately doubling every 5 years of increment of
age: 50–54 (0.3%; 95% CI: 0.1, 0.7), 55–59 (0.5%; 95%
CI: 0.3, 0.7), 60–64 (1.1%; 95% CI: 0.8, 1.4), 65–69
(2.0%; 95% CI: 1.6, 2.3), 70–74 (3.6%; 95% CI: 3.0,
4.2), 75–79 (5.9%; 95% CI: 5.1, 6.8), 80–84 (10.9%;
95% CI: 9.3, 12.4), 85–89 (18.5%; 95% CI: 14.5, 22.4),
90þ (28.6%; 95% CI: 24.3, 32.9). Six studies did not re-
port age-stratified prevalence and therefore age standar-
dization was applied to 90 surveys. The overall estimate of
age-standardized prevalence was 4.5% (95% CI: 4.1, 4.9;
I2 ¼ 98.4%).
As in the previous review, diagnostic criteria, whole
study age range, population size and sampling method
remained important in explaining the heterogeneity
across individual studies (Model 1, Table 1). Studies using
Figure 1. Flow chart of literature search.
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Figure 2. Forest plot of crude prevalence: 96 included studies reporting prevalence in people aged 50 or above.
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DSM-III/III-R, the International Classification of Diseases
(ICD) and the Chinese Classification of Mental Disorders
(CCMD) and mixed criteria (pooled estimate: 2.5%, 95%
CI: 2.1, 2.9) generally reported lower prevalence than
those using DSM-IV/IV-R and other criteria (pooled esti-
mate: 5.7%; 95% CI: 5.0, 6.5). Pooled estimates of preva-
lence increased with whole study age range. Studies with
large sample sizes (5000þ) reported lower prevalence than
those with sample size less than 5000. Studies conducting
cluster-based sampling were likely to report lower preva-
lence compared with those using other types of sampling
methods.
The unadjusted pooled estimate for northern China
(5.4%; 95% CI: 4.3, 6.4) was higher than for central
China (3.8%; 95% CI: 3.1, 4.4) and south China (3.7%;
95% CI: 3.0, 4.4) but was lower than for west China
(9.6%; 95% CI: 4.5, 14.8). Pooled prevalence in Hong
Kong and Taiwan was 4.0% (95% CI: 2.7, 5.4). The
prevalence of dementia varied across geographical areas
after adjusting for study design, methodological factors
and year of investigation (Table 1). The absolute difference
from northern areas of China was about 1% in central
areas (1.0; 95% CI: 2.2, 0.3), 2% in south areas (1.7;
95% CI: 3.1, 0.3), 3% in Hong Kong and Taiwan
Figure 3. Prevalence estimates in the population aged 60 or above across time periods.
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(3.0; 95% CI: 5.0, 1.0) and 3% in west areas of
China (2.8%; 95% CI: 0.1, 5.5).
Crude prevalence increased from 1.9% (95% CI: 1.0,
2.9) before 1990 to 6.4% (95% CI: 5.2, 7.7) in 2010–15,
with a clear increasing trend. After adjusting for methodo-
logical factors and geographical areas, the apparent
increasing trend was attenuated (Figure 3A). Although the
adjusted estimate in 2010–15 (4.9%; 95% CI: 2.8, 7.0)
was nearly twice as high as the prevalence reported from
five studies before 1990 (2.8%; 95% CI: 0.4, 5.2), the vari-
ation in dementia prevalence after 1990 was unclear and
regional trends revealed considerable fluctuation across the
time periods (Figure 3B). In particular, trends in 24 studies
from Beijing and Shanghai, the only two areas with studies
before 1990, showed an even dramatic fluctuation after
adjusting for methodological factors.
Based on the results of DSM-IV/IV-R, Table 2 reports
estimated numbers of people with dementia by geograph-
ical areas, which show substantial difference in meta-
regression modelling. In China, the estimated number of
people with dementia was 9.5 million in those aged 60 or
over (5.3%, 95% CI: 4.3, 6.3) and 3.5 million of these
were in northern China (5.5%; 95% CI: 4.3, 6.7). New es-
timates for people aged 65 or above were 0.07 million in
Hong Kong (7.2%; 95% CI: 5.3, 9.1) and 0.15 million in
Taiwan (6.0%; 95% CI: 4.1, 7.9).
Discussion
This updated review has identified 20 prevalence studies in
addition to the 76 studies included in the earlier review,
and confirmed geographical variation and time trends re-
ported in the previous analyses.13,14 The prevalence of de-
mentia decreases from northern, central and southern
China to the lowest in Hong Kong and Taiwan, but a par-
ticularly high estimate was found in western China. The
apparent increasing prevalence across time is attenuated
once adjusted for methodological factors and geographical
areas. Regional patterns over time reveal considerable fluc-
tuations. The current best estimate for number of people
with dementia in this region as a whole is 9.5 million
(5.3%; 95% CI: 4.3, 6.3) in the population aged 60 or
above.
Compared with other existing systematic reviews, this
analysis investigated geographical variation and time
trends taking important methodological factors and char-
acteristics of study population into account, and used re-
gional prevalence estimates and population data to model
number of people with dementia by different areas. To
examine the potential interaction of geographies and time,
this review further explored regional trends in Beijing and
Shanghai since the late 1980s.
There are some limitations in this review. The three lit-
erature searches were conducted at different time points,
due to limited research funding and resources. Although
this might introduce bias, the updated searches included a
short overlapping period from the earlier searches in order
to ensure that the same studies were identified. Results of
literature searches were also compared with the reference
lists of existing systematic reviews. The study protocol was
not registered or published before the review being con-
ducted, but this update generally followed the study meth-
ods and procedures used in our earlier studies. It is possible
that unpublished data or local investigations might exist
for less developed areas but are not available in the public
domain. Although some new investigations have been con-
ducted in north-western provinces, most studies are con-
centrated in Shanghai and relatively wealthy areas. The
current estimates are still mainly based on the studies exist-
ing in highly developed areas and, from the indicators of
regional variation, these might not fully represent substan-
tial variation across China. Although the analysis investi-
gated potential sources of heterogeneity, considerable
inconsistency of prevalence estimates across studies could
Table 2. Estimated numbers of people with dementia in mainland China, Hong Kong and Taiwan (millions) based on DSM-IV/IV-R
criteria
Area Older populationa Number of people with
dementia (millions)
Prevalence
(%, 95% CI)
China North 63.9 3.52 5.5 (4.3, 6.7)
(age 60þ)a Central 73.3 3.79 5.2 (4.0, 6.4)
South 30.9 1.48 4.8 (3.5, 6.1)
West 9.5 0.69 7.2 (4.6, 9.8)
Total 177.6 9.48 5.3 (4.3, 6.3)
Hong Kong (age 65þ)a 0.9 0.07 7.2 (5.3, 9.1)
Taiwan (age 65þ)a 2.5 0.15 6.0 (4.1, 7.9)
Total 181.0 9.70 5.3 (4.3, 6.3)
aThe estimation for Hong Kong and Taiwan focused on the population aged 65 or over as most studies in these two areas recruited participants aged 65 or
over.
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not be fully explained by methodological variation. It is
possible that some unmeasured factors and characteristics
of study population, such as mortality, might influence
prevalence estimates in the study population, but such in-
formation could not be extracted from the publications.
The number of people with dementia was calculated based
on the modelling results, and therefore estimates are sensi-
tive to small differences in regression coefficients.
Although changes in prevalence did not achieve statistical
significance, the numbers calculated using the time point
estimate will still vary substantially because of the sheer
size of the Chinese older population.
The study quality was not related to variation in preva-
lence estimates and did not considerably change over time.
However, most two-stage studies did not include a sample
of screen negatives and appropriate weights. The quality of
reporting also varied across individual studies. For ex-
ample, although two-thirds of studies had high response
rates (> 80%), 22% did not report such information and
selection bias in these studies was unknown. Some short re-
ports did not provide detailed information on research
methods or study populations. Such lack of detail may lead
to unexplained heterogeneity in the meta-analysis. In add-
ition, a relatively small number of studies (9%) used com-
prehensive diagnostic assessment, including multi-domain
cognitive tests, disability assessment and informant and
clinical interviews. Implementation of dementia diagnosis
might be compromised due to incomplete information on
cognitive and functional status.
The 20 new studies contributed a quarter of the total
database and continue to highlight potential variation in
cognitive health within East Asia. Our earlier review and
this update suggest similar findings of geographical vari-
ation: prevalence estimates were higher in the north, with
lower estimates further south after adjustment for meth-
odological factors. In addition, studies from western China
appear to provide distinct estimates compared with the
north in this new analysis, and showed a particularly high
pooled estimate. This might indicate a complicated and
prolonged influence of societal contexts on individual life
experiences, behaviours and health conditions, which may
affect health and cognition in later life. Regional differ-
ences in life course exposures such as education, smoking,
nutrition and diet,31 as well as potential environmental
risk factors such as sunshine and Vitamin D intake,32 air
pollution33 and health services,34 may play a part in gen-
eral health and subsequent risk of dementia and provide a
possible explanation of geographical variation. In particu-
lar, Uyghur and other ethnic minorities in western areas
have very different lifestyle, culture and environment from
the Han Chinese and generally experience high levels of de-
privation.35 Variation in education, general health and life
experiences between Uyghur and Han might contribute to
differences in cognitive health at older ages. Urban and
rural differences have been reported in a recent multicentre
study6 but the analysis here could not explore specific esti-
mates for urban-rural areas due to different definitions of
urban and rural settings across studies. Improving report-
ing on geographical locality characteristics would enable
this to be explored further.
The new studies have provided more data on prevalence
estimates in the past 5 years. The unadjusted pooled preva-
lence has increased over time with the highest in the most re-
cent period group (2010–15), but this difference can be
largely attributed to changes in diagnostic criteria and study
methods as well as geographical variation within China.
The findings confirm an increasingly recognized phenom-
enon of the major influence of diagnostic methods on preva-
lence estimates.36 Further adjustment for geographical areas
and subgroup analyses on regional trends also considerably
attenuated increasing prevalence across time. Although the
adjusted estimate in 2010–15 was twice as high as the one
for the oldest group (before 1990), the estimate from the
pre-1990 period is highly atypical, as these early studies
only focused on relatively small areas in metropolitan cities
(Beijing and Shanghai). The research context of these old in-
vestigations is therefore very different from that of more re-
cent studies. In particular, the second edition of the Chinese
Classification of Mental Disorders (CCMD-2) was pub-
lished in 1989.37 Development of psychiatric knowledge
and the adaptation of new criteria change case identification
and prevalence estimates across time. Although several
existing reviews have suggested that the prevalence of de-
mentia might have increased across time, given the rising in-
cidence of chronic conditions such as diabetes, vascular
diseases and metabolic syndrome,12,38 the scale of increase
cannot be determined unless the effect of different diagnos-
tic criteria and methodologies can be accounted for first.
What is unclear in all the changes to diagnostic criteria over
the time periods is how differently each set of diagnostic cri-
teria predicts natural history and, indeed, whether the most
recent changes lead to greater misclassification (i.e. more
false positives).
Despite marginal changes in prevalence estimates, the
new estimated number of people (9.5 million) is one million
higher than the previous estimate (8.4 million). In the World
Alzheimer Report 2015, the estimate for East Asia was 9.8
million based on recent studies in China (published after
2005).12 Although these differences reflect different statis-
tical aspects of estimation and varying sources of standard
population data, small changes in prevalence estimates
could indicate enormous impact on health and social care
systems and the whole society. The changing meaning of de-
mentia diagnoses and measurement modalities needs close
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attention, as an increase of 1 million people at the very mild
end of the spectrum, which may include false positives or
people with low likelihood of progression, has very different
implications for society compared with an increase of 1 mil-
lion moderately to severely affected people.
Although population ageing, changes in lifestyle and rise
in chronic diseases might increase the risk of dementia in
older populations,31 recent epidemiological studies in high-in-
come countries have reported stable or reduced prevalence of
dementia over the past 2 decades.39 Possible explanation of
these decreasing trends has been related to the improvement
of education, living conditions and lifestyle and reduction in
chronic conditions.40 Although overall prevalence trends in
mainland China, Hong Kong and Taiwan are uncertain due
to the substantial impact of methodological variation, geo-
graphical variation within this region might provide an op-
portunity to investigate these hypotheses. Differences in
economic and societal development across China may be po-
tential contexts for natural experiment research.
High quality primary research is needed in this region in
order to provide robust prevalence estimates and evidence
for policy planning. In recent years, international organ-
izations and civil societies have focused on promoting
national plans for dementia.41 In addition to these
dementia-specific policies, public health policy planning
needs to adopt a comprehensive approach to improve gen-
eral health in populations and to address determinants of
cognitive health across the life course, in order to inform
prevention or risk reduction strategies.40
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